CHOICE OF ANTITHROMBOTIC DRUG IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD PRACTICE

被引：0
|
作者：
Citarella, A. [1 ]
Cammarota, S. [1 ]
Creazzola, S. [2 ]
De Marino, C. [2 ]
Izzo, P. [2 ]
La Bella, G. [2 ]
Piscitelli, R. [2 ]
Romagnuolo, F. [2 ]
Esposito, E. [2 ]
Guida, A. [2 ]
机构：
[1] LinkHealth Srl, Naples, Italy
[2] Local Hlth Author, Naples, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.806
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV38
引用
收藏
页码：A380 / A380
页数：1
相关论文
共 50 条
  • [21] Non-valvular atrial fibrillation: evaluation of thromboembolic risk and antithrombotic treatment in a population of patients in general practice
    Del Zotti, Francesco
    Gottardi, Giobatta
    Frapporti, Guglielmo
    Micchi, Alessio
    Zanolla, Luisa
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (04) : 313 - 317
  • [22] Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Alberts, Mark J.
    Eikelboom, John W.
    Hankey, Graeme J.
    LANCET NEUROLOGY, 2012, 11 (12): : 1066 - 1081
  • [23] Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation
    Jolobe, Oscar M. P.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (07) : 416 - 416
  • [24] Effectiveness and Safety of Dabigatran and Warfarin in Real-World US Patients With Non-Valvular Atrial Fibrillation: A Retrospective Cohort Study
    Lauffenburger, Julie C.
    Farley, Joel F.
    Gehi, Anil K.
    Rhoney, Denise H.
    Brookhart, M. Alan
    Fang, Gang
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (04):
  • [25] Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
    Tepper, Ping G.
    Mardekian, Jack
    Masseria, Cristina
    Phatak, Hemant
    Kamble, Shital
    Abdulsattar, Younos
    Petkun, William
    Lip, Gregory Y. H.
    PLOS ONE, 2018, 13 (11):
  • [26] Peripheral leukocyte count and risk of bleeding in patients with non-valvular atrial fibrillation taking dabigatran: a real-world study
    Zhou, Wei
    Wang, Tao
    Zhu, Ling-Juan
    Wen, Ming-Hua
    Hu, Li-Hua
    Huang, Xiao
    You, Chun-Jiao
    Li, Ju-Xiang
    Wu, Yan-Qing
    Wu, Qing-Hua
    Bao, Hui-Hui
    Cheng, Xiao-Shu
    CHINESE MEDICAL JOURNAL, 2019, 132 (18) : 2150 - 2156
  • [27] Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation
    Yuji Murakawa
    Takanori Ikeda
    Satoshi Ogawa
    Takanari Kitazono
    Jyoji Nakagawara
    Kazuo Minematsu
    Susumu Miyamoto
    Yasuhiro Hayashi
    Yoko Kidani
    Yutaka Okayama
    Toshiyuki Sunaya
    Shoichiro Sato
    Satoshi Yamanaka
    Heart and Vessels, 2020, 35 : 1125 - 1134
  • [28] COMPARISON OF TREATMENT PERSISTENCE IN THE REAL-WORLD USE OF NOVEL ORAL ANTICOAGULANTS AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Lefevre, Cinira
    Johnson, Michelle
    Collings, Shuk-Li
    Evans, David
    Kloss, Sebastian
    Ridha, Essra
    Maguire, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 792 - 792
  • [29] Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation
    Murakawa, Yuji
    Ikeda, Takanori
    Ogawa, Satoshi
    Kitazono, Takanari
    Nakagawara, Jyoji
    Minematsu, Kazuo
    Miyamoto, Susumu
    Hayashi, Yasuhiro
    Kidani, Yoko
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Sato, Shoichiro
    Yamanaka, Satoshi
    HEART AND VESSELS, 2020, 35 (08) : 1125 - 1134
  • [30] Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation - a real world analysis
    Brizido, Catarina
    Ferreira, Antonio Miguel
    Lopes, Pedro
    Strong, Christopher
    Mendes, Gustavo Sa
    Gama, Francisco Fernandes
    Durazzo, Anai
    Rodrigues, Gustavo Rocha
    Matos, Daniel
    Guerreiro, Sara
    Madeira, Sergio
    Ferreira, Jorge
    Adragao, Pedro
    Mendes, Miguel
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (09) : 669 - 675
12345